• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

工具变量法协调了实用癌症筛查试验中的意图筛查效应。

Instrumental variables methods reconcile intention-to-screen effects across pragmatic cancer screening trials.

机构信息

Department of Economics and National Bureau of Economic Research, Massachusetts Institute of Technology, Cambridge, MA 02142.

Department of Economics and National Bureau of Economic Research, Brown University, Providence, RI 02912.

出版信息

Proc Natl Acad Sci U S A. 2023 Dec 19;120(51):e2311556120. doi: 10.1073/pnas.2311556120. Epub 2023 Dec 15.

DOI:10.1073/pnas.2311556120
PMID:38100416
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10742387/
Abstract

Pragmatic cancer screening trials mimic real-world scenarios in which patients and doctors are the ultimate arbiters of treatment. Intention-to-screen (ITS) analyses of such trials maintain randomization-based apples-to-apples comparisons, but differential adherence (the failure of subjects assigned to screening to get screened) makes ITS effects hard to compare across trials and sites. We show how instrumental variables (IV) methods address the nonadherence challenge in a comparison of estimates from 17 sites in five randomized trials measuring screening effects on colorectal cancer incidence. While adherence rates and ITS estimates vary widely across and within trials, IV estimates of per-protocol screening effects are remarkably consistent. An application of simple IV tools, including graphical analysis and formal statistical tests, shows how differential adherence explains variation in ITS impact. Screening compliers are also shown to have demographic characteristics similar to those of the full trial study sample. These findings argue for the clinical relevance of IV estimates of cancer screening effects.

摘要

实用癌症筛查试验模拟了实际情况下患者和医生是治疗的最终决策者的场景。对这些试验进行的意向性筛查(ITS)分析保留了基于随机分组的苹果对苹果的比较,但由于存在差异的依从性(被分配到筛查组的受试者未能接受筛查),使得 ITS 效果难以在不同试验和地点之间进行比较。我们展示了如何在比较五个随机试验中 17 个地点的估计值时,使用工具变量(IV)方法来解决非依从性挑战,这些试验测量了筛查对结直肠癌发病率的影响。虽然依从率和 ITS 估计值在试验之间和内部差异很大,但基于方案的筛查效果的 IV 估计值非常一致。简单 IV 工具的应用,包括图形分析和正式的统计检验,表明了差异的依从性如何解释 ITS 影响的变化。还表明,筛查顺从者具有与整个试验研究样本相似的人口统计学特征。这些发现证明了癌症筛查效果的 IV 估计值的临床相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba19/10742387/a3c13b8c6b65/pnas.2311556120fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba19/10742387/2d1008e17b46/pnas.2311556120fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba19/10742387/a3c13b8c6b65/pnas.2311556120fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba19/10742387/2d1008e17b46/pnas.2311556120fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba19/10742387/a3c13b8c6b65/pnas.2311556120fig02.jpg

相似文献

1
Instrumental variables methods reconcile intention-to-screen effects across pragmatic cancer screening trials.工具变量法协调了实用癌症筛查试验中的意图筛查效应。
Proc Natl Acad Sci U S A. 2023 Dec 19;120(51):e2311556120. doi: 10.1073/pnas.2311556120. Epub 2023 Dec 15.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.流行病学方法与应用概述:观察性研究设计的优势与局限性。
Crit Rev Food Sci Nutr. 2010;50 Suppl 1(s1):10-2. doi: 10.1080/10408398.2010.526838.
4
Analysis approaches to address treatment nonadherence in pragmatic trials with point-treatment settings: a simulation study.解决具有点治疗设置的实用临床试验中治疗不依从性的分析方法:一项模拟研究。
BMC Med Res Methodol. 2022 Feb 16;22(1):46. doi: 10.1186/s12874-022-01518-8.
5
Patients and investigators prefer measures of absolute risk in subgroups for pragmatic randomized trials.患者和研究者更倾向于实用随机试验亚组的绝对风险指标。
J Clin Epidemiol. 2018 Nov;103:10-21. doi: 10.1016/j.jclinepi.2018.06.009. Epub 2018 Jun 30.
6
Patient Centered Hazard Ratio Estimation Using Principal Stratification Weights: Application to the NORCCAP Randomized Trial of Colorectal Cancer Screening.使用主分层权重进行以患者为中心的风险比估计:在NORCCAP结直肠癌筛查随机试验中的应用。
Obs Stud. 2016 Mar;2:29-50. Epub 2016 Apr 24.
7
In the era of widespread endoscopy use, randomized trials may strongly underestimate the effects of colorectal cancer screening.在广泛应用内窥镜检查的时代,随机试验可能严重低估结直肠癌筛查的效果。
J Clin Epidemiol. 2013 Oct;66(10):1144-50. doi: 10.1016/j.jclinepi.2013.05.008. Epub 2013 Jul 11.
8
Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies.筛查乙状结肠镜检查和筛查结肠镜检查对结直肠癌发病率和死亡率的影响:随机对照试验和观察性研究的系统评价和荟萃分析。
BMJ. 2014 Apr 9;348:g2467. doi: 10.1136/bmj.g2467.
9
Per-Protocol analyses produced larger treatment effect sizes than intention to treat: a meta-epidemiological study.按方案分析产生的治疗效果比意向治疗更大:一项meta 流行病学研究。
J Clin Epidemiol. 2021 Oct;138:12-21. doi: 10.1016/j.jclinepi.2021.06.010. Epub 2021 Jun 20.
10
Single CT colonography versus three rounds of faecal immunochemical test for population-based screening of colorectal cancer (SAVE): a randomised controlled trial.基于人群的结直肠癌筛查:单剂量CT结肠成像与三轮粪便免疫化学检测对比研究(SAVE):一项随机对照试验
Lancet Gastroenterol Hepatol. 2022 Nov;7(11):1016-1023. doi: 10.1016/S2468-1253(22)00269-2. Epub 2022 Sep 16.

引用本文的文献

1
Instrumental Variables Methods Reveal Larger Effects of Menopausal Hormone Therapy in the Landmark Women's Health Initiative Clinical Trial.工具变量法揭示了绝经激素治疗在具有里程碑意义的女性健康倡议临床试验中的更大效果。
AEA Pap Proc. 2025 May;115:215-220. doi: 10.1257/pandp.20251064.
2
Atrial fibrillation screening for stroke prevention: an instrumental variables meta-analysis addressing varying participation rates.用于预防中风的房颤筛查:一项针对不同参与率的工具变量荟萃分析。
Europace. 2025 Feb 5;27(2). doi: 10.1093/europace/euaf030.
3
Estimating the Effects of Cancer Screening in Clinical Practice Settings: The Role of Selective Uptake and Suboptimal Adherence along the Cancer Screening Continuum.

本文引用的文献

1
Behaviour within a Clinical Trial and Implications for Mammography Guidelines.临床试验中的行为及其对乳腺钼靶检查指南的影响。
Rev Econ Stud. 2023 Jan;90(1):432-462. doi: 10.1093/restud/rdac022. Epub 2022 May 9.
2
Colonoscopy Screening and Colorectal Cancer Incidence and Mortality. Reply.结肠镜检查筛查与结直肠癌发病率和死亡率。回复。
N Engl J Med. 2023 Jan 26;388(4):378-379. doi: 10.1056/NEJMc2215192.
3
Colonoscopy Screening and Colorectal Cancer Incidence and Mortality.结肠镜检查筛查与结直肠癌的发病率和死亡率
评估临床实践环境中癌症筛查的效果:癌症筛查连续过程中选择性接受和次优依从性的作用。
Cancer Epidemiol Biomarkers Prev. 2024 Aug 1;33(8):984-988. doi: 10.1158/1055-9965.EPI-23-1491.
4
Instrumental variables for implementation science: exploring context-dependent causal pathways between implementation strategies and evidence-based interventions.实施科学的工具性变量:探索实施策略与循证干预措施之间的情境依赖因果路径。
Implement Sci Commun. 2023 Dec 20;4(1):157. doi: 10.1186/s43058-023-00536-x.
N Engl J Med. 2023 Jan 26;388(4):377. doi: 10.1056/NEJMc2215192.
4
15-Year Benefits of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality : A Pooled Analysis of Randomized Trials.15 年乙状结肠镜筛查对结直肠癌发病率和死亡率的获益:随机试验的汇总分析。
Ann Intern Med. 2022 Nov;175(11):1525-1533. doi: 10.7326/M22-0835. Epub 2022 Oct 11.
5
Understanding the Results of a Randomized Trial of Screening Colonoscopy.解读结肠镜筛查随机试验的结果
N Engl J Med. 2022 Oct 27;387(17):1609-1611. doi: 10.1056/NEJMe2211595. Epub 2022 Oct 9.
6
Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death.结肠镜筛查对结直肠癌发病风险和相关死亡的影响。
N Engl J Med. 2022 Oct 27;387(17):1547-1556. doi: 10.1056/NEJMoa2208375. Epub 2022 Oct 9.
7
Long-Term Follow-up of the Italian Flexible Sigmoidoscopy Screening Trial.意大利柔性乙状结肠镜筛查试验的长期随访。
Ann Intern Med. 2022 Jan;175(1):36-45. doi: 10.7326/M21-0977. Epub 2021 Nov 9.
8
Doubly robust nonparametric instrumental variable estimators for survival outcomes.用于生存结局的双重稳健非参数工具变量估计量。
Biostatistics. 2023 Apr 14;24(2):518-537. doi: 10.1093/biostatistics/kxab036.
9
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.mRNA-1273 新型冠状病毒疫苗在盲法阶段完成时的效力。
N Engl J Med. 2021 Nov 4;385(19):1774-1785. doi: 10.1056/NEJMoa2113017. Epub 2021 Sep 22.
10
Mammograms and Mortality: How Has the Evidence Evolved?乳房X光检查与死亡率:证据是如何演变的?
J Econ Perspect. 2021 Spring;35(2):119-140. doi: 10.1257/jep.35.2.119.